Nov 5, 4:16 PM ET
DXP Enterprises reported third quarter 2026 results for the period ended September 30, 2026, with sales of $587.2 million, up 14.3% from a year earlier, and net income of $26.9 million, up 24.2%. Diluted earnings per share were $1.64 compared with $1.31 in the third quarter of 2025, and the company completed five acquisitions through the quarter.
- Sales were $587.2 million versus $513.7 million in the third quarter of 2025; acquisitions contributed $48.8 million.
- Net income was $26.9 million versus $21.6 million; diluted EPS was $1.64 versus $1.31.
- Adjusted EBITDA was $67.3 million, up 19.0%, with an Adjusted EBITDA margin of 11.5% versus 11.0%.
- Free cash flow was $14.4 million versus $28.1 million a year earlier; total debt was $839.5 million as of September 30, 2026.
Read the filing on SEC.gov ↗
Oct 28, 5:44 PM ET
DXP Enterprises' Board authorized a new program to repurchase up to $150.0 million or 1.0 million shares of common stock over the next 24 months, at management's discretion. The new program follows a previous $85.0 million or 2.5 million share program that concluded in August 2026, and the company may discontinue it at any time.
- Up to $150.0 million or 1.0 million shares may be repurchased over the next 24 months
- Previous program authorized up to $85.0 million or 2.5 million shares and concluded in August 2026
- Approximately 16.4 million diluted weighted average shares outstanding as of June 30, 2026
- Repurchases may occur in open market or privately negotiated transactions; no guarantee of exact amount
Read the filing on SEC.gov ↗
Aug 6, 2:28 PM ET
DXP Enterprises reported second quarter 2026 results for the period ended June 30, 2026. Sales rose 15.6% year over year to $576.5 million, and GAAP diluted EPS was $1.76, up from $1.43, while net income increased 21.6% to $28.7 million. The filing gives no financial guidance, and the company said it closed four acquisitions in the first half of 2026.
- Sales of $576.5 million, up 15.6% from $498.7 million; acquisitions contributed $49.8 million
- GAAP diluted EPS of $1.76 versus $1.43; Adjusted EBITDA of $70.4 million, up 22.8%
- Free cash flow of $29.8 million versus $8.3 million a year earlier; total debt was $842.5 million at June 30, 2026
Read the filing on SEC.gov ↗
Jul 9, 7:15 PM ET
DXP Enterprises entered a Second Amended and Restated Loan Agreement on July 2, 2026, increasing commitments under its asset-based revolving credit facility by $40 million. The facility now totals $225 million and matures on July 2, 2031. The company says the change maintains liquidity, supports its acquisition strategy, and positions it to optimize its cost of capital.
- Total ABL commitments rise from $185 million to $225 million, a $40 million increase.
- Up to $210 million is available to US borrowers and up to $15 million to Canadian borrowers.
- Interest accrues at Term SOFR or Term CORRA plus 1.25% to 1.75%, or at alternate base rates plus 0.25% to 0.75%, based on average daily excess availability.
- The facility may be increased by up to $50 million in total, in minimum increments of $10 million, subject to conditions; Bank of America, N.A. is agent.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.